How Can I Simultaneously Optimize TAVI and Future Coronary Access? Lifetime Management of Patients With Severe AS Without Compromise









  • Views:

    Views Icon 6320
  • Likes:

    Heart Icon 12


Coronary Artery Disease (CAD) is present in 60–70% of current TAVI patients1. Future TAVI patients will be treated at a younger age with longer life expectancy who may develop CAD. Therefore easy coronary access is paramount to treat current and future patient populations safely2.

This webinar aims to illustrate how to optimize procedural outcomes by using commissural alignment to preserve coronary access3,4 and increase options for possible future interventions.


Performed By:

Joanna J Wykrzykowska

Joanna J Wykrzykowska

Dr Rik van der Werf

Dr Rik van der Werf

Moderated By:

Flavio Ribichini

Flavio Ribichini

Mohamed Abdel-Wahab

Mohamed Abdel-Wahab

This webinar is supported by:


Welcome & Intro

Flavio Luciano Ribichini
16:00 - 16:02 CEST

Coronary access after TAVI: Why bother?

Mohamed Abdel-Wahab
16:02 - 16:12 CEST

Live Case Live from Groningen, Netherlands

Joanna Wykrzykowska
16:12 - 16:42 CEST

Faculty Discussion

All faculty
16:42 - 16:58 CEST


Mohammed Abdel-Wahab
16:58 - 17:00 CEST

Key Learning Objectives

  • Step by step demonstration how to perform commissural alignment
  • Understand current and predicted trends in TAVI with respect to preserving coronary access
  • Share experience and discuss lifetime management of patients with severe AS with consideration of factors for choosing valves in low risk populations

Target Audience

  • Interventional Cardiologists
  • Cardiac Surgeons
  • Interventional Fellows
  • TAVI Experts
  • Complex PCI experts

Faculty Biographies

Joanna J Wykrzykowska

Joanna J Wykrzykowska

View full profile
Dr Rik van der Werf

Dr Rik van der Werf

View full profile
Flavio Ribichini

Flavio Ribichini

Medical degree obtained in 1986, at the National University of Cordoba, Argentina.
Fellow in Internal Medicine in 1987-88.
Board in Cardiology obtained at the University of Torino, Italy in 1992.
Training stages in interventional cardiology at the University of Paris VII, Henry Mondor Hospital in 1994, Stanford University, Stanford, CA in 1995 and Mount Sinai Medical School, New York in 1996.

Research Fellow of the ESC in 1997-98 at the OLVZ Cardiovascular Centre in Aalst, Belgium.
Assistant Professor of Cardiology and Director of the Catheterization Laboratory of the University.
The Cardiovascular Interventional Unit of Verona performs coronary and peripheral interventions (over 2000 diagnostic and 800 interventional cases per year of which approximately 100 TAVI), with a 24 hours emergency service for the City area of Verona (500.000 habitants). It is the Provincial referring centre for primary angioplasty, paediatric invasive cardiology, and structural cardiology. Is the Regional referring centre for renal denervation, and is a training centre for visitor cardiologists interested in IVUS, FFR, rotational atherectomy, TAVI, mitral, and peripheral interventions.

Reviewer of several scientific journals among which Circulation, Journal of the American College of Cardiology, European Heart Journal, Atherosclerosis Thrombosis and Vascular Biology, Heart, Clinical Chemistry, The American Journal of Cardiology, Eurointervention, American Journal of Medicine, and The Lancet.
Coordinator, Principal Investigator or member of the steering committees of several clinical trials.
Author of over 180 full publications on clinical and basic cardiovascular research in peer reviewed scientific journals available on PubMed.

View full profile
Mohamed Abdel-Wahab

Mohamed Abdel-Wahab

Internationally renowned interventional cardiologist specialized in TAVI and complex coronary interventions. Head of the department of structural heart disease at Heart Center Leipzig, the largest European center in terms of number of TAVI procedures. Professor Abdel-Wahab has contributed to over 200 papers in the field of interventional cardiology in high profile peer review journals.

View full profile

Key References

1. T. Lefèvre, A.P. Kappetein, E. Wolner, et al., PARTNER EY Investigator Group
One year follow-up of the multi-centre European PARTNER transcatheter heart valve study

2. Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation.
Lunardi M, Pighi M, Venturi G, Del Sole PA, Pesarini G, Mainardi A, Scarsini R, Ferrero V, Gottin L, Ribichini F.
J Clin Med. 2020 Dec 31;10(1):112. doi: 10.3390/jcm10010112.
PMID: 33396185 Free PMC article.

3. Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves.
Bieliauskas G, Wong I, Bajoras V, Wang X, Kofoed KF, De Backer O, Søndergaard L.
JACC Cardiovasc Interv. 2021 Sep 8:S1936-8798(21)01233-4. doi: 10.1016/j.jcin.2021.06.033. Online ahead of print.
PMID: 34538602

4. Commissural Alignment of the ACURATE neo Valve in Transcatheter Aortic Valve Replacement.
Kitamura M, Wilde J, Gohmann R, Majunke N, Gutberlet M, Shibata M, Kiefer P, Desch S, Thiele H, Holzhey D, Abdel-Wahab M.
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1740-1742. doi: 10.1016/j.jcin.2021.05.037.
PMID: 34353607 No abstract available.